BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11115234)

  • 1. Epilepsy and the immune system.
    Aarli JA
    Arch Neurol; 2000 Dec; 57(12):1689-92. PubMed ID: 11115234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.
    Levite M; Ganor Y
    Expert Rev Neurother; 2008 Jul; 8(7):1141-60. PubMed ID: 18590483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures.
    Mantegazza R; Bernasconi P; Baggi F; Spreafico R; Ragona F; Antozzi C; Bernardi G; Granata T
    J Neuroimmunol; 2002 Oct; 131(1-2):179-85. PubMed ID: 12458050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis.
    Rogers SW; Andrews PI; Gahring LC; Whisenand T; Cauley K; Crain B; Hughes TE; Heinemann SF; McNamara JO
    Science; 1994 Jul; 265(5172):648-51. PubMed ID: 8036512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasmussen's encephalitis: an autoimmune disorder?
    Andrews PI; McNamara JO
    Curr Opin Neurobiol; 1996 Oct; 6(5):673-8. PubMed ID: 8937833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis.
    Watson R; Jiang Y; Bermudez I; Houlihan L; Clover L; McKnight K; Cross JH; Hart IK; Roubertie A; Valmier J; Hart Y; Palace J; Beeson D; Vincent A; Lang B
    Neurology; 2004 Jul; 63(1):43-50. PubMed ID: 15249609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New autoantibody mediated disorders of the central nervous system.
    Lang B; Dale RC; Vincent A
    Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor GluR3.
    Krauss GL; Campbell ML; Roche KW; Huganir RL; Niedermeyer E
    Neurology; 1996 Jan; 46(1):247-9. PubMed ID: 8559386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate receptor GluR3 antibodies and death of cortical cells.
    He XP; Patel M; Whitney KD; Janumpalli S; Tenner A; McNamara JO
    Neuron; 1998 Jan; 20(1):153-63. PubMed ID: 9459451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rasmussen Syndrome and Other Inflammatory Epilepsies.
    Varadkar S; Cross JH
    Semin Neurol; 2015 Jun; 35(3):259-68. PubMed ID: 26060905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological aspects of epilepsy.
    Zarczuk R; Łukasik D; Jedrych M; Borowicz KK
    Pharmacol Rep; 2010; 62(4):592-607. PubMed ID: 20885000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies linked to rare epilepsy.
    Barinaga M
    Science; 1995 Apr; 268(5209):362-3. PubMed ID: 7716535
    [No Abstract]   [Full Text] [Related]  

  • 13. An unusual case of coma related to glutamate receptor 3 (GluR3) auto-antibodies after a traumatic spinal cord injury: Clinical and pathological aspects.
    Caputo F; Barranco R; Ricci P; Gratteri S; Castelletti L; Ravetti GL; Ventura F
    Med Leg J; 2021 Jun; 89(2):133-136. PubMed ID: 33331219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights.
    Levite M; Goldberg H
    Front Immunol; 2021; 12():762743. PubMed ID: 35095841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and pathogenic significance of glutamate receptor autoantibodies.
    Pleasure D
    Arch Neurol; 2008 May; 65(5):589-92. PubMed ID: 18474732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoantibodies to glutamate, GABA and their receptors in epilepsy].
    Vetrile LA; Karpova MN; Kuznetzova LV
    Patol Fiziol Eksp Ter; 2015; 59(1):90-8. PubMed ID: 26226695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease.
    Tan TH; Perucca P; O'Brien TJ; Kwan P; Monif M
    Epilepsia; 2021 Feb; 62(2):303-324. PubMed ID: 33316111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins.
    Vincent A; Irani SR; Lang B
    Curr Opin Neurol; 2010 Apr; 23(2):144-50. PubMed ID: 20164770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.
    Wiendl H; Bien CG; Bernasconi P; Fleckenstein B; Elger CE; Dichgans J; Mantegazza R; Melms A
    Neurology; 2001 Oct; 57(8):1511-4. PubMed ID: 11673604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
    Daif A; Lukas RV; Issa NP; Javed A; VanHaerents S; Reder AT; Tao JX; Warnke P; Rose S; Towle VL; Wu S
    Epilepsy Behav; 2018 Mar; 80():331-336. PubMed ID: 29433947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.